90 related articles for article (PubMed ID: 24460250)
1. How to establish acute myeloid leukemia xenograft models using immunodeficient mice.
Shan WL; Ma XL
Asian Pac J Cancer Prev; 2013; 14(12):7057-63. PubMed ID: 24460250
[TBL] [Abstract][Full Text] [Related]
2. Animal models of acute myelogenous leukaemia - development, application and future perspectives.
McCormack E; Bruserud O; Gjertsen BT
Leukemia; 2005 May; 19(5):687-706. PubMed ID: 15759039
[TBL] [Abstract][Full Text] [Related]
3. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.
Vick B; Rothenberg M; Sandhöfer N; Carlet M; Finkenzeller C; Krupka C; Grunert M; Trumpp A; Corbacioglu S; Ebinger M; André MC; Hiddemann W; Schneider S; Subklewe M; Metzeler KH; Spiekermann K; Jeremias I
PLoS One; 2015; 10(3):e0120925. PubMed ID: 25793878
[TBL] [Abstract][Full Text] [Related]
4. A robust xenotransplantation model for acute myeloid leukemia.
Sanchez PV; Perry RL; Sarry JE; Perl AE; Murphy K; Swider CR; Bagg A; Choi JK; Biegel JA; Danet-Desnoyers G; Carroll M
Leukemia; 2009 Nov; 23(11):2109-17. PubMed ID: 19626050
[TBL] [Abstract][Full Text] [Related]
5. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.
Saland E; Boutzen H; Castellano R; Pouyet L; Griessinger E; Larrue C; de Toni F; Scotland S; David M; Danet-Desnoyers G; Vergez F; Barreira Y; Collette Y; Récher C; Sarry JE
Blood Cancer J; 2015 Mar; 5(3):e297. PubMed ID: 25794133
[TBL] [Abstract][Full Text] [Related]
6. Humanized model to study leukemic stem cells.
Bonnet D
Methods Mol Biol; 2009; 538():247-62. PubMed ID: 19277589
[TBL] [Abstract][Full Text] [Related]
7. An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia.
Her Z; Yong KSM; Paramasivam K; Tan WWS; Chan XY; Tan SY; Liu M; Fan Y; Linn YC; Hui KM; Surana U; Chen Q
J Hematol Oncol; 2017 Oct; 10(1):162. PubMed ID: 28985760
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I
Clin Cancer Res; 2012 Mar; 18(6):1630-40. PubMed ID: 22383738
[TBL] [Abstract][Full Text] [Related]
9. Xenograft Models of Primary Acute Myeloid Leukemia for the Development of Imaging Strategies and Evaluation of Novel Targeted Therapies.
Gelebart P; Popa M; McCormack E
Curr Pharm Biotechnol; 2016; 17(1):42-51. PubMed ID: 26278528
[TBL] [Abstract][Full Text] [Related]
10. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
11. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
[TBL] [Abstract][Full Text] [Related]
12. Induction and Therapeutic Targeting of Human NPM1c
Kaur M; Drake AC; Hu G; Rudnick S; Chen Q; Phennicie R; Attar R; Nemeth J; Gaudet F; Chen J
J Immunol; 2019 Mar; 202(6):1885-1894. PubMed ID: 30710044
[TBL] [Abstract][Full Text] [Related]
13. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
14. Lessons from models of murine erythroleukemia to acute myeloid leukemia (AML): proof-of-principle of co-operativity in AML.
Moreau-Gachelin F
Haematologica; 2006 Dec; 91(12):1644-52. PubMed ID: 17145601
[TBL] [Abstract][Full Text] [Related]
15. Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo.
Sergeeva A; He H; Ruisaard K; St John L; Alatrash G; Clise-Dwyer K; Li D; Patenia R; Hong R; Sukhumalchandra P; You MJ; Gagea M; Ma Q; Molldrem JJ
Leukemia; 2016 Jul; 30(7):1475-84. PubMed ID: 27055866
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
17. Efficient RNA Interference of Primary Leukemic Cells for Loss-of-Function Studies in Xenograft Mouse Models.
Nicolis di Robilant B; Noviello M
Methods Mol Biol; 2016; 1393():113-26. PubMed ID: 27033221
[TBL] [Abstract][Full Text] [Related]
18. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
[TBL] [Abstract][Full Text] [Related]
19. Murine models of human acute myeloid leukemia.
Fortier JM; Graubert TA
Cancer Treat Res; 2010; 145():183-96. PubMed ID: 20306252
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
